Since the launch of their covid-19 vaccines, Moderna and Pfizer have accumulated more than $100bn (£83; €94) in global revenues from sales—more than 20 times the World Health Organization’s biennial budget in 2020-21. Yet for a vaccine that is estimated to cost $1-3 per dose to manufacture, both Moderna and Pfizer have announced plans to charge more than $110 a dose in the US this year—a price that Moderna’s CEO Stéphan Bancel has argued is “consistent with the value” of these vaccines.” But value for whom?...........To Read More....